Inflammatory Bone Loss: Pathogenesis and Therapeutic Intervention

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2012 Mar 2

PMID 22378270

Citations 353

Authors

Kurt Redlich

Josef S Smolen

Affiliations

Soon will be listed here.

Abstract

Bone is a tissue undergoing continuous building and degradation. This remodelling is a tightly regulated process that can be disturbed by many factors, particularly hormonal changes. Chronic inflammation can also perturb bone metabolism and promote increased bone loss. Inflammatory diseases can arise all over the body, including in the musculoskeletal system (for example, rheumatoid arthritis), the intestine (for example, inflammatory bowel disease), the oral cavity (for example, periodontitis) and the lung (for example, cystic fibrosis). Wherever inflammatory diseases occur, systemic effects on bone will ensue, as well as increased fracture risk. Here, we discuss the cellular and signalling pathways underlying, and strategies for therapeutically interfering with, the inflammatory loss of bone.

Citing Articles

Serum A20 level is associated with bone mineral density in male patients with type 2 diabetes mellitus.

Han D, Liu J, Wang Y, Wang H, Yuan L, Jin W Front Endocrinol (Lausanne). 2025; 16:1490214.

PMID: 40078583 PMC: 11899168. DOI: 10.3389/fendo.2025.1490214.

Relationship between systemic inflammatory response index and bone mineral density in children and adolescents aged 8-19 years: a cross-sectional study based on NHANES 2011-2016.

Cun D, Yang N, Zhou L, Zeng W, Chen B, Pan Z Front Endocrinol (Lausanne). 2025; 16:1537574.

PMID: 40070585 PMC: 11893988. DOI: 10.3389/fendo.2025.1537574.

Melatonin attenuates inflammatory bone loss by alleviating mitophagy and lactate production.

Lin Z, Gu Y, Liu Y, Chen Z, Fang S, Wang Z Apoptosis. 2025; .

PMID: 40064756 DOI: 10.1007/s10495-025-02096-y.

Exploring precision treatments in immune-mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery.

Xu L, Shao Z, Fang X, Xin Z, Zhao S, Zhang H Exploration (Beijing). 2025; 5(1):20230165.

PMID: 40040830 PMC: 11875455. DOI: 10.1002/EXP.20230165.

SARS-CoV-2 Impairs Osteoblast Differentiation Through Spike Glycoprotein and Cytokine Dysregulation.

Freiberger R, Lopez C, Jarmoluk P, Palma M, Cevallos C, Sviercz F Viruses. 2025; 17(2).

PMID: 40006897 PMC: 11860324. DOI: 10.3390/v17020143.

References

Brown E, Edberg J, Kimberly R . Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity. 2007; 40(8):567-81. DOI: 10.1080/08916930701763710. View

Hein G, Eidner T, Oelzner P, Rose M, Wilke A, Wolf G . Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study. Rheumatol Int. 2010; 31(2):269-72. DOI: 10.1007/s00296-010-1560-9. View

Sims N, Walsh N . GP130 cytokines and bone remodelling in health and disease. BMB Rep. 2010; 43(8):513-23. DOI: 10.5483/bmbrep.2010.43.8.513. View

Kim J, Chen J . regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes. 2004; 53(11):2748-56. DOI: 10.2337/diabetes.53.11.2748. View

Lian J, Stein G, Javed A, van Wijnen A, Stein J, Montecino M . Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord. 2006; 7(1-2):1-16. DOI: 10.1007/s11154-006-9001-5. View

Ding J, Ghali O, Lencel P, Broux O, Chauveau C, Devedjian J . TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci. 2009; 84(15-16):499-504. DOI: 10.1016/j.lfs.2009.01.013. View

Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux N . B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 2006; 169(3):987-98. PMC: 1698808. DOI: 10.2353/ajpath.2006.060180. View

Kushner I . Regulation of the acute phase response by cytokines. Perspect Biol Med. 1993; 36(4):611-22. DOI: 10.1353/pbm.1993.0004. View

Mocsai A, Humphrey M, Van Ziffle J, Hu Y, Burghardt A, Spusta S . The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004; 101(16):6158-63. PMC: 395939. DOI: 10.1073/pnas.0401602101. View

10.

Schonthaler H, Guinea-Viniegra J, Wagner E . Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis. 2011; 70 Suppl 1:i109-12. DOI: 10.1136/ard.2010.140533. View

11.

Sethi G, Sung B, Aggarwal B . TNF: a master switch for inflammation to cancer. Front Biosci. 2008; 13:5094-107. DOI: 10.2741/3066. View

12.

Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B . The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003; 349(26):2483-94. DOI: 10.1056/NEJMoa030847. View

13.

Jarrett S, Conaghan P, Sloan V, Papanastasiou P, Ortmann C, OConnor P . Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum. 2006; 54(5):1410-4. DOI: 10.1002/art.21824. View

14.

Tracey K, Cerami A . Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994; 45:491-503. DOI: 10.1146/annurev.med.45.1.491. View

15.

Romero G, Sneddon W, Yang Y, Wheeler D, Blair H, Friedman P . Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis. J Biol Chem. 2010; 285(19):14756-63. PMC: 2863183. DOI: 10.1074/jbc.M110.102970. View

16.

Gortz B, Hayer S, Redlich K, Zwerina J, Tohidast-Akrad M, Tuerk B . Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res. 2004; 19(6):990-8. DOI: 10.1359/JBMR.040205. View

17.

Zvaifler N . Rheumatoid synovitis. An extravascular immune complex disease. Arthritis Rheum. 1974; 17(3):297-305. DOI: 10.1002/art.1780170315. View

18.

Colucci S, Brunetti G, Cantatore F, Oranger A, Mori G, Quarta L . Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol. 2007; 212(1):47-55. DOI: 10.1002/path.2153. View

19.

Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus A, Kainberger F . Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007; 56(4):1118-24. DOI: 10.1002/art.22496. View

20.

Rowan A, Koshy P, Shingleton W, Degnan B, Heath J, Vernallis A . Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum. 2001; 44(7):1620-32. DOI: 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B. View